Format
Sort by
Items per page

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 162

1.

Monitoring influenza virus susceptibility to oseltamivir using a new rapid assay, iART.

Gubareva LV, Fallows E, Mishin VP, Hodges E, Brooks A, Barnes J, Fry AM, Kramp W, Shively R, Wentworth DE, Weidemaier K, Jacobson R.

Euro Surveill. 2017 May 4;22(18). pii: 30529. doi: 10.2807/1560-7917.ES.2017.22.18.30529.

2.

Antiviral Drug-Resistant Influenza B Viruses Carrying H134N Substitution in Neuraminidase, Laos, February 2016.

Baranovich T, Vongphrachanh P, Ketmayoon P, Sisouk T, Chomlasack K, Khanthamaly V, Nguyen HT, Mishin VP, Marjuki H, Barnes JR, Garten RJ, Stevens J, Wentworth DE, Gubareva LV.

Emerg Infect Dis. 2017 Apr;23(4):686-690. doi: 10.3201/eid2304.161876.

3.

Increase in Human Infections with Avian Influenza A(H7N9) Virus During the Fifth Epidemic - China, October 2016-February 2017.

Iuliano AD, Jang Y, Jones J, Davis CT, Wentworth DE, Uyeki TM, Roguski K, Thompson MG, Gubareva L, Fry AM, Burns E, Trock S, Zhou S, Katz JM, Jernigan DB.

MMWR Morb Mortal Wkly Rep. 2017 Mar 10;66(9):254-255. doi: 10.15585/mmwr.mm6609e2.

4.

Update: Influenza Activity - United States, October 2, 2016-February 4, 2017.

Blanton L, Mustaquim D, Alabi N, Kniss K, Kramer N, Budd A, Garg S, Cummings CN, Fry AM, Bresee J, Sessions W, Garten R, Xu X, Elal AI, Gubareva L, Barnes J, Wentworth DE, Burns E, Katz J, Jernigan D, Brammer L.

MMWR Morb Mortal Wkly Rep. 2017 Feb 17;66(6):159-166. doi: 10.15585/mmwr.mm6606a2.

5.

Quantification of Influenza Neuraminidase Activity by Ultra-High Performance Liquid Chromatography and Isotope Dilution Mass Spectrometry.

Solano MI, Woolfitt AR, Williams TL, Pierce CL, Gubareva LV, Mishin V, Barr JR.

Anal Chem. 2017 Mar 7;89(5):3130-3137. doi: 10.1021/acs.analchem.6b04902. Epub 2017 Feb 21.

PMID:
28192976
6.

Update: Influenza Activity - United States, October 2-December 17, 2016.

Shang M, Blanton L, Kniss K, Mustaquim D, Alabi N, Barnes S, Budd A, Davlin SL, Kramer N, Garg S, Cummings CN, Flannery B, Fry AM, Grohskopf LA, Olsen SJ, Bresee J, Sessions W, Garten R, Xu X, Elal AI, Gubareva L, Barnes J, Wentworth DE, Burns E, Katz J, Jernigan D, Brammer L.

MMWR Morb Mortal Wkly Rep. 2016 Dec 30;65(5051):1439-1444. doi: 10.15585/mmwr.mm655051a5.

7.

A Pyrosequencing-Based Approach to High-Throughput Identification of Influenza A(H3N2) Virus Clades Harboring Antigenic Drift Variants.

Mishin VP, Baranovich T, Garten R, Chesnokov A, Abd Elal AI, Adamczyk M, LaPlante J, St George K, Fry AM, Barnes J, Chester SC, Xu X, Katz JM, Wentworth DE, Gubareva LV.

J Clin Microbiol. 2016 Dec 28;55(1):145-154. doi: 10.1128/JCM.01840-16. Print 2017 Jan.

PMID:
27795346
8.

Update: Influenza Activity - United States and Worldwide, May 22-September 10, 2016.

Budd A, Blanton L, Kniss K, Smith S, Mustaquim D, Davlin SL, Kramer N, Flannery B, Fry AM, Grohskopf LA, Olsen SJ, Bresee J, Sessions W, Garten R, Xu X, Elal AI, Gubareva L, Barnes J, Wentworth DE, Burns E, Katz J, Jernigan D, Brammer L.

MMWR Morb Mortal Wkly Rep. 2016 Sep 23;65(37):1008-1014. doi: 10.15585/mmwr.mm6537a5.

9.

Human Monoclonal Antibody 81.39a Effectively Neutralizes Emerging Influenza A Viruses of Group 1 and 2 Hemagglutinins.

Marjuki H, Mishin VP, Chai N, Tan MW, Newton EM, Tegeris J, Erlandson K, Willis M, Jones J, Davis T, Stevens J, Gubareva LV.

J Virol. 2016 Nov 14;90(23):10446-10458. Print 2016 Dec 1.

10.

A randomized, double-blind, placebo-controlled trial evaluating the safety of early oseltamivir treatment among children 0-9 years of age hospitalized with influenza in El Salvador and Panama.

Dawood FS, Jara J, Gonzalez R, Castillo JM, De León T, Estripeaut D, Luciani K, Sujey Brizuela Y, Barahona A, Cazares RA, Lawson AM, Rodriguez M, de Viana D, Franco D, Castillo M, Fry AM, Gubareva L, Tamura D, Hughes M, Gargiullo P, Clara W, Azziz-Baumgartner E, Widdowson MA.

Antiviral Res. 2016 Sep;133:85-94. doi: 10.1016/j.antiviral.2016.07.007. Epub 2016 Jul 21.

PMID:
27451343
11.

Influenza Activity - United States, 2015-16 Season and Composition of the 2016-17 Influenza Vaccine.

Davlin SL, Blanton L, Kniss K, Mustaquim D, Smith S, Kramer N, Cohen J, Cummings CN, Garg S, Flannery B, Fry AM, Grohskopf LA, Bresee J, Wallis T, Sessions W, Garten R, Xu X, Elal AI, Gubareva L, Barnes J, Wentworth DE, Burns E, Katz J, Jernigan D, Brammer L.

MMWR Morb Mortal Wkly Rep. 2016 Jun 10;65(22):567-75. doi: 10.15585/mmwr.mm6522a3.

12.

Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2014-2015.

Hurt AC, Besselaar TG, Daniels RS, Ermetal B, Fry A, Gubareva L, Huang W, Lackenby A, Lee RT, Lo J, Maurer-Stroh S, Nguyen HT, Pereyaslov D, Rebelo-de-Andrade H, Siqueira MM, Takashita E, Tashiro M, Tilmanis D, Wang D, Zhang W, Meijer A.

Antiviral Res. 2016 Aug;132:178-85. doi: 10.1016/j.antiviral.2016.06.001. Epub 2016 Jun 3.

13.

Enhanced Genetic Characterization of Influenza A(H3N2) Viruses and Vaccine Effectiveness by Genetic Group, 2014-2015.

Flannery B, Zimmerman RK, Gubareva LV, Garten RJ, Chung JR, Nowalk MP, Jackson ML, Jackson LA, Monto AS, Ohmit SE, Belongia EA, McLean HQ, Gaglani M, Piedra PA, Mishin VP, Chesnokov AP, Spencer S, Thaker SN, Barnes JR, Foust A, Sessions W, Xu X, Katz J, Fry AM.

J Infect Dis. 2016 Oct 1;214(7):1010-9. doi: 10.1093/infdis/jiw181. Epub 2016 May 6.

PMID:
27190176
14.

Molecular Characterizations of Surface Proteins Hemagglutinin and Neuraminidase from Recent H5Nx Avian Influenza Viruses.

Yang H, Carney PJ, Mishin VP, Guo Z, Chang JC, Wentworth DE, Gubareva LV, Stevens J.

J Virol. 2016 May 27;90(12):5770-84. doi: 10.1128/JVI.00180-16. Print 2016 Jun 15.

15.

Update: Influenza Activity--United States, October 4, 2015-February 6, 2016.

Russell K, Blanton L, Kniss K, Mustaquim D, Smith S, Cohen J, Garg S, Flannery B, Fry AM, Grohskopf LA, Bresee J, Wallis T, Sessions W, Garten R, Xu X, Elal AI, Gubareva L, Barnes J, Wentworth DE, Burns E, Katz J, Jernigan D, Brammer L.

MMWR Morb Mortal Wkly Rep. 2016 Feb 19;65(6):146-53. doi: 10.15585/mmwr.mm6506a3.

16.

Standardizing the influenza neuraminidase inhibition assay among United States public health laboratories conducting virological surveillance.

Okomo-Adhiambo M, Mishin VP, Sleeman K, Saguar E, Guevara H, Reisdorf E, Griesser RH, Spackman KJ, Mendenhall M, Carlos MP, Healey B, St George K, Laplante J, Aden T, Chester S, Xu X, Gubareva LV.

Antiviral Res. 2016 Apr;128:28-35. doi: 10.1016/j.antiviral.2016.01.009. Epub 2016 Jan 22.

PMID:
26808479
17.

Effectiveness of seasonal influenza vaccine in preventing influenza primary care visits and hospitalisation in Auckland, New Zealand in 2015: interim estimates.

Bissielo A, Pierse N, Huang QS, Thompson MG, Kelly H, Mishin VP, Turner N; SHIVERS.

Euro Surveill. 2016;21(1). doi: 10.2807/1560-7917.ES.2016.21.1.30101.

18.

Update: Influenza Activity - United States.

Smith S, Blanton L, Kniss K, Mustaquim D, Steffens C, Reed C, Bramley A, Flannery B, Fry AM, Grohskopf LA, Bresee J, Wallis T, Garten R, Xu X, Elal AI, Gubareva L, Barnes J, Wentworth DE, Burns E, Katz J, Jernigan D, Brammer L.

MMWR Morb Mortal Wkly Rep. 2015 Dec 11;64(48):1342-8. doi: 10.15585/mmwr.mm6448a4.

19.

Update: Influenza Activity--United States and Worldwide, May 24-September 5, 2015.

Blanton L, Kniss K, Smith S, Mustaquim D, Steffens C, Flannery B, Fry AM, Bresee J, Wallis T, Garten R, Xu X, Elal AI, Gubareva L, Wentworth DE, Burns E, Katz J, Jernigan D, Brammer L.

MMWR Morb Mortal Wkly Rep. 2015 Sep 18;64(36):1011-6. doi: 10.15585/mmwr.mm6436a4.

20.

Detection and Characterization of Clade 1 Reassortant H5N1 Viruses Isolated from Human Cases in Vietnam during 2013.

Thor SW, Nguyen H, Balish A, Hoang AN, Gustin KM, Nhung PT, Jones J, Thu NN, Davis W, Ngoc TN, Jang Y, Sleeman K, Villanueva J, Kile J, Gubareva LV, Lindstrom S, Tumpey TM, Davis CT, Long NT.

PLoS One. 2015 Aug 5;10(8):e0133867. doi: 10.1371/journal.pone.0133867. eCollection 2015.

Supplemental Content

Loading ...
Support Center